Last reviewed · How we verify
Daily FSH and GnRH antagonist — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Daily FSH and GnRH antagonist (Daily FSH and GnRH antagonist) — Bioroma.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Daily FSH and GnRH antagonist TARGET | Daily FSH and GnRH antagonist | Bioroma | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Daily FSH and GnRH antagonist CI watch — RSS
- Daily FSH and GnRH antagonist CI watch — Atom
- Daily FSH and GnRH antagonist CI watch — JSON
- Daily FSH and GnRH antagonist alone — RSS
Cite this brief
Drug Landscape (2026). Daily FSH and GnRH antagonist — Competitive Intelligence Brief. https://druglandscape.com/ci/daily-fsh-and-gnrh-antagonist. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab